By Ria Kakkad (Drug Target Review)2023-07-06T16:14:08
The use of animal studies in drug development has become a growing ethical concern, particularly given the high failure rate of clinical trials, which can reach up to 90 percent. This article highlights non-animal models that could expedite the drug delivery process from bench to bedside.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-01-16T10:21:42
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2023-01-04T16:08:55
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2024-02-02T15:48:26
Sponsored by Bio-Techne
2023-01-06T16:37:30
Sponsored by Catalent
2024-02-08T11:07:39
Sponsored by Samplix ApS
2023-01-10T09:50:16
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
Site powered by Webvision Cloud